Phlox Therapeutics
Latest round
- Seed
Last raised
- Nov 2024
Total raised
- $2.1M
Investors
- 4
About Phlox Therapeutics
Founded in 2022 and based in North Holland, Netherlands, Phlox Therapeutics BV specializes in gene therapy aimed at treating genetic heart diseases. Yigal Pinto (CMO) and Eva van Rooij (CSO) are the co-founders of the company. Phlox Therapeutics specializes in gene therapy to address various genetic heart diseases, focusing primarily on the development of innovative RNA-based therapies for cardiomyopathies. The firm’s core product offerings revolve around precision genetic medicines designed to target the underlying causes of cardiac dysfunction, aiming to alleviate symptoms and halt disease progression. These therapies are intended for patients suffering from rare genetic conditions, particularly genetic laminopathies and other forms of cardiomyopathy. Phlox's solutions are designed for a global market, with a particular emphasis on regions where access to advanced therapeutic options for heart diseases is limited, thereby targeting patients and healthcare providers in North America and Europe. Phlox Therapeutics engages in transactions primarily through strategic partnerships and collaborations aimed at advancing the research and development of its RNA therapies. Revenue generation may arise from partnerships with research institutions and healthcare organizations that provide access to clinical trial participants and resources for testing these novel therapies.
Who invested in Phlox Therapeutics
4 investors across 3 rounds
See all investors in Phlox Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Phlox Therapeutics
Who invested in Phlox Therapeutics?
Phlox Therapeutics has 4 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Phlox Therapeutics raised?
Phlox Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Phlox Therapeutics last raise money?
Phlox Therapeutics's most recent round on record is a Seed, in Nov 2024.
What does Phlox Therapeutics do?
Founded in 2022 and based in North Holland, Netherlands, Phlox Therapeutics BV specializes in gene therapy aimed at treating genetic heart diseases.
Where is Phlox Therapeutics headquartered?
Phlox Therapeutics is headquartered in North Holland, Netherlands.
Which VCs invest in companies like Phlox Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at Phlox Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Phlox Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.